从2006年开始,国家发改委将与卫生部合作,选择部分政府定价药品,从出厂定价到医院终端售出进行全程监控,严格控制其出厂价格,限制进入医院差价率。这是国家发改委为缓解群众看病难、看病贵问题将要推出的系列措施之一。国家发改委价格司有关人员说,医药利益挂钩是导致群众看病 Starting in 2006, the National Development and Reform Commission will work with the Ministry of Health to select some government-priced drugs, conduct full monitoring from factory pricing to hospital terminal sales, strictly control their ex-factory prices, and limit the rate of entry into the hospital. This is one of a series of measures that the National Development and Reform Commission will launch to alleviate the difficulty of the people’s medical care and expensive medical services. The relevant staff of the National Development and Reform Commission’s Price Department said that the link of medical interests is causing people to see the disease.